ABT Revenue 2026

Annual and quarterly sales data for Abbott Laboratories

Latest Annual Revenue

$44.33B

2025-12-31

YoY Growth

+5.7%

vs. previous year

4-Year CAGR

2.5%

compound growth

Annual Revenue History

2025-12-31

$44.33B

YoY Growth

+5.7%

2024-12-31

$41.95B

YoY Growth

+0.0%

2024-12-31

$41.95B

YoY Growth

+4.6%

2023-12-31

$40.11B

YoY Growth

+0.0%

2023-12-31

$40.11B

Quarterly Revenue Breakdown

2025-09-30

$11.37B

2025-09-30

$11.37B

2025-06-30

$11.14B

2025-06-30

$11.14B

2025-03-31

$10.36B

2025-03-31

$10.36B

2024-09-30

$10.63B

2024-09-30

$10.63B

Revenue by Segment

Total Revenue$44.33B (100.0%)

Get Full ABT Financial Analysis

View complete income statements, balance sheets, and AI-powered insights

Frequently Asked Questions

What is ABT's revenue?

ABT (Abbott Laboratories) reported $44.33 billion in revenue for 2025-12-31. This represents a 5.7% increase compared to the previous year.

How much revenue does ABT make per year?

Abbott Laboratories generates approximately $44.33 billion in annual revenue based on the most recent fiscal year ending 2025-12-31.

Is ABT revenue growing?

Yes, ABT's revenue is growing. The company achieved 5.7% revenue growth year-over-year. Over the past 4 years, revenue has grown at a compound annual growth rate (CAGR) of 2.5%.

What is ABT's quarterly revenue?

ABT reported $11.37 billion in revenue for the most recent quarter (2025-09-30).

What are ABT's revenue sources?

ABT's revenue comes from multiple segments: Total Revenue. See the revenue breakdown below for detailed segment analysis.

How does ABT compare to competitors in revenue?

ABT generates $44.33 billion in annual revenue in the Health Care sector. Compare ABT to competitors using our stock comparison tool to see relative market share and growth rates.

Disclaimer: Revenue data is based on publicly filed financial statements. Historical performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.

Explore Categories